Question 1

Am I eligible to participate in this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00111618). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of AS1404 and docetaxel compare to other treatments available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00111618). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of AS1404 when combined with docetaxel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00111618). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00111618). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment period in terms of monitoring and assessments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00111618). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks or concerns I should be aware of before joining this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00111618). Contact the study team or your healthcare provider for specific answers.

What this study is about